Pharmaceuticals

Oligonucleotide Therapy Industry Anticipated to Expand at 11.8% CAGR During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Oligonucleotide Therapy Market By 2029?

The oligonucleotide therapy market has experienced substantial growth in recent years. It is anticipated to expand from $5.61 billion in 2024 to $6.2 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.5%. This historical expansion can be attributed to increased investment in research and development, the market introduction of initial therapies, the advancement of gene editing techniques, fundamental therapeutic discoveries, and the emergence of RNAi and antisense oligonucleotide technologies.

The oligonucleotide therapy market is projected to experience swift expansion in the coming years, anticipated to reach $9.66 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. The growth during this forecast period can be attributed to significant research and development investments, increasing global market penetration, expansion into new therapeutic areas, innovative disease modification strategies, and regulatory adaptations. Major trends expected in the forecast period include the development of customized therapies, advancements in delivery systems, breakthroughs in RNA interference (RNAi), continued innovation in antisense oligonucleotides, and the integration of gene editing techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

Which Industry Drivers Are Expected To Accelerate The Oligonucleotide Therapy Market From 2025 To 2029?

The global increase in cancer cases is expected to contribute to the expansion of the oligonucleotide therapy market throughout the forecast period. For example, the American Cancer Society reported in January 2022 that the US is likely to see 1.9 million new cancer diagnoses and 609,360 cancer-related deaths, equating to approximately 1,670 fatalities daily. Worldwide, lung, prostate, bowel, and female breast cancer are the four most prevalent types, together accounting for 43% of all new cancer cases. Therefore, the escalating global cancer incidence rates are anticipated to significantly boost demand for the oligonucleotide therapy market in the forthcoming years.

What Are The Emerging Segments Gaining Attention In The Oligonucleotide Therapy Market?

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

What Trends Are Redefining The Oligonucleotide Therapy Market Dynamics?

Companies operating within the oligonucleotide therapy market are dedicating investments to research and development efforts to redesign therapeutic approaches and lessen their side effects on patients. These advanced and innovative oligonucleotides facilitate precision medicine methods and can be engineered to specifically target any gene while inducing minimal side effects. They are also instrumental in targeting patient-specific genetic sequences that are implicated in rare diseases. In April 2023, the FDA granted approval to Qalsody, an antisense oligonucleotide (ASO), for managing amyotrophic lateral sclerosis (ALS) in patients with a superoxide dismutase 1 (SOD1) gene mutation. Qalsody functions by targeting SOD1 mRNA to decrease the production of SOD1 protein.

Who Are The Top Performing Companies In The Oligonucleotide Therapy Market In Recent Years?

Major companies operating in the oligonucleotide therapy market include Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Gilead Sciences Inc., BioNTech SE, Moderna Inc., Biogen Inc., Jazz Pharmaceuticals plc, QIAGEN Company, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Dynacure S.A., Arcturus Therapeutics Holdings Inc., Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc., Editas Medicine Inc., Evox Therapeutics Ltd., PepGen Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

What Regional Growth Trends Are Shaping The Oligonucleotide Therapy Market Outlook?

North America was the largest region in the oligonucleotide therapy market in 2024. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oligonucleotide Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3398&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Therapy Market 2025, By The Business Research Company

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Pharmaceutical Api Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795